Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Airos Medical, GE Healthcare, Gynesonics, Quest Diagnostics.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Atlas Group, Beckman Coulter, Chf Solutions, Dynatrace, Epineuron, Ergotron, Ert, Guided Therapeutics, I-Med Pharma, Itg Isotope, Itm Isotopen, Jama Software, Labcorp, Life Spine, Merck, Mcra, Medable, Netsmart Technologies, Oncimmune, Orthogenrx, Reflexion Medical, Renovacare, Roche, Shandong Yaohua Medical Instrument, Synergy Laboratories, Transimed Medical Equipment, Vaxxas.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Livanova.

Med-tech firms raising money in public or private financings, including: Boston Scientific, Ginkgo Bioworks, Hemaflo Therapeutics, Illumina, Nuvasive, Penumbra, Syapse.

New hires and promotions in the med-tech industry, including: Edap Tms, Eyecarrot Innovations, Medx Health.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ashvattha, Basilea, Bird Rock, Cardiff, Cerecor, Chiesi, Immodulon, Macrogenics, Moleculin, Orpheris, Phasebio, Protalix, Roche, Theraly.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aerpio, Alkido, Anergis, Astrazeneca, Cabaletta, Chimeron, CNS Pharmaceuticals, Daiichi Sankyo, Denali Therapeutics, E-therapeutics, GNS Healthcare, Kiadis Pharma, Merck, Microbion, Moderna, Oncimmune, Oxford Biomedica, Puretech, Reflexion, Restorbio, Roche, SAB, Stallergenes Greer, Syneos Health, Vaxxas.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akcea, Apellis, Atriva, Calcimedica, Enlivex, Genentech, Genmab, I-Mab, Ionis, Iovance, Neurotrope, Oncopeptides, Partner Therapeutics, Windmil, Zai.

Biopharmas raising money in public or private financings, including: Arcus, Arena, Argenx, Axonis, Biocryst, Caladrius, Genprex, Geron, Hemaflo, Iovance, Mersana, Viela Bio, Xbrane.

New hires and promotions in the biopharma industry, including: Acadia, Arcutis, Biosig, Crinetics, Histogen, Maat, NGM.